New to Animal Pharm?
Start a free trial today to access this content and much more.
If your company has access but you haven't yet registered, click below:
Zoetis, Virbac and Dechra show durability as H1 highlights impact of foreign exchange
Zoetis has outstripped its competitors during the first half of the year, with higher growth sales than any of the other billion-dollar businesses in animal health.
Elanco and Bayer deal taps into emerging trends shaping a modern animal health sector
Elanco's pending purchase of Bayer Animal Health is a deal that capitalizes on industry trends that have emerged this year, claims chief executive Jeff Simmons.
Elanco to buy Bayer Animal Health in industry's largest-ever acquisition
Elanco has entered into an agreement to acquire Bayer's animal health division in a deal valued at around $7.6 billion.
Agile Sciences believes it can 're-energize' animal health's faith in antibiotics
Agile Sciences claims its naturally-sourced compounds could reinvigorate the use of antibiotics against drug-resistant bacterial infections. Malcolm Thomas – chief executive of the Raleigh, North Carolina-based start-up – told Animal Pharm editor Joseph Harvey how the company's technology might impact the animal health sector.
IDEXX highlights blockbuster potential for preventative pet diagnostics
IDEXX Laboratories has emphasized the large addressable market for companion animal diagnostics, especially with the growing adoption of preventative testing.
Experts outline ramifications of revised European bioequivalence studies guideline
Cemile Jakupoglu of Cyton Germany and Maggie Fisher of the UK's Veterinary Research Management give Animal Pharm an overview of the major changes involved in the revised EU guideline on the conduct of bioequivalence studies for veterinary medicinal products, which came into play this year.
Latest Articles
Advertisement
Recent Tweets from Animal Pharm
Tweets by animalpharm
Advertisement
Advertisement
Commercial
Elanco continues to purchase partners with $60m deal for Prevtec Microbia
Elanco has significantly bolstered its swine vaccine portfolio by acquiring Canadian company Prevtec Microbia.
Latest From
Panion makes board changes, appoints new chairmen
Swedish firm Panion Animal Health has named Arne Ferstad and Jan Nilsson as new chairmen of the company.
ECO restructures board, names new chief financial officer
UK firm ECO Animal Health has carried out a restructuring of its board after several resignations and appointed Christopher Wilks to the role of chief financial officer.
Laboratorios Over aims to expand beyond Argentina, increase vaccine output
Argentina's Laboratorios Over intends to take its animal health portfolio to wider markets beyond its domestic focus.
FAO calls on African governments to regulate urban livestock space
Based on new report findings, the FAO has warned a growing farming sector around African cities poses a public health threat if not properly regulated.
Kane posts strong Q2 and H1 sales, builds on record-breaking first quarter
Canadian firm Kane Biotech has recorded robust year-on-year growth in the second quarter of 2019.
Stonehaven strengthens team with ex-Elanco marketing specialist
Global life sciences management specialist Stonehaven Consulting has selected Arthur Redpath to the firm as a senior global marketing expert.
Top Interviews & Analysis
Next-frontier translational technologies and trends – Part Three: Digital technology and data
In the last of a three-part series for Animal Pharm, Stonehaven Consulting partners Benjamin Wilhelm and Adrian Grosu put the use of digital technology and data in human health under the spotlight, as they explain how these innovations can be expected to cross over into animal health.
India's animal health sector shows resilience in face of domestic economic slowdown
Bioceltix: Stem cell pathway made easier by first European commercialization
PanTheryx funding will help intensify growth in animal microbiome-focused products
From critic to chief: Carolin Schumacher begins to shape GALVmed strategy for 2030
Products
After the isoxazoline gold rush: Where will industry turn for next big antiparasitic windfall?
The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market.
Latest From
Panion makes board changes, appoints new chairmen
Swedish firm Panion Animal Health has named Arne Ferstad and Jan Nilsson as new chairmen of the company.
ECO restructures board, names new chief financial officer
UK firm ECO Animal Health has carried out a restructuring of its board after several resignations and appointed Christopher Wilks to the role of chief financial officer.
Laboratorios Over aims to expand beyond Argentina, increase vaccine output
Argentina's Laboratorios Over intends to take its animal health portfolio to wider markets beyond its domestic focus.
FAO calls on African governments to regulate urban livestock space
Based on new report findings, the FAO has warned a growing farming sector around African cities poses a public health threat if not properly regulated.
Kane posts strong Q2 and H1 sales, builds on record-breaking first quarter
Canadian firm Kane Biotech has recorded robust year-on-year growth in the second quarter of 2019.
Stonehaven strengthens team with ex-Elanco marketing specialist
Global life sciences management specialist Stonehaven Consulting has selected Arthur Redpath to the firm as a senior global marketing expert.
Data Pharm
Zoetis full-year guidance goes back up after Abaxis-aided growth in Q2
Zoetis has secured 9% sales growth in the second quarter of 2019, with its companion animal unit providing a stand-out performance.
Bayer sales flat in second quarter following expected US decline
Bayer Animal Health posted revenues of €454 million ($506 million) during the second quarter of 2019 – in line with sales at this point last year.
Sectors
Guggenheim on companion animal health: Next five years could see as much growth as last half century
In a new report, David Westenberg – an analyst at US investment firm Guggenheim Partners – has made multiple predictions for the companion animal health market of 2024. Animal Pharm editor Joseph Harvey looks through these forecasts to find out what the next five years might have in store.
Latest From
Panion makes board changes, appoints new chairmen
Swedish firm Panion Animal Health has named Arne Ferstad and Jan Nilsson as new chairmen of the company.
ECO restructures board, names new chief financial officer
UK firm ECO Animal Health has carried out a restructuring of its board after several resignations and appointed Christopher Wilks to the role of chief financial officer.
Laboratorios Over aims to expand beyond Argentina, increase vaccine output
Argentina's Laboratorios Over intends to take its animal health portfolio to wider markets beyond its domestic focus.
FAO calls on African governments to regulate urban livestock space
Based on new report findings, the FAO has warned a growing farming sector around African cities poses a public health threat if not properly regulated.
Kane posts strong Q2 and H1 sales, builds on record-breaking first quarter
Canadian firm Kane Biotech has recorded robust year-on-year growth in the second quarter of 2019.
Stonehaven strengthens team with ex-Elanco marketing specialist
Global life sciences management specialist Stonehaven Consulting has selected Arthur Redpath to the firm as a senior global marketing expert.
Latest From
Panion makes board changes, appoints new chairmen
Swedish firm Panion Animal Health has named Arne Ferstad and Jan Nilsson as new chairmen of the company.
ECO restructures board, names new chief financial officer
UK firm ECO Animal Health has carried out a restructuring of its board after several resignations and appointed Christopher Wilks to the role of chief financial officer.
Laboratorios Over aims to expand beyond Argentina, increase vaccine output
Argentina's Laboratorios Over intends to take its animal health portfolio to wider markets beyond its domestic focus.
FAO calls on African governments to regulate urban livestock space
Based on new report findings, the FAO has warned a growing farming sector around African cities poses a public health threat if not properly regulated.
Kane posts strong Q2 and H1 sales, builds on record-breaking first quarter
Canadian firm Kane Biotech has recorded robust year-on-year growth in the second quarter of 2019.
Stonehaven strengthens team with ex-Elanco marketing specialist
Global life sciences management specialist Stonehaven Consulting has selected Arthur Redpath to the firm as a senior global marketing expert.
Policy & Regulation
Experts err on the side of caution over forthcoming European regulations
A joint conference hosted by AnimalhealthEurope and Klifovet in Munich gave a detailed overview of the new European regulation on veterinary medicines and the impact it will have on product development and lifecycle management. Animal Pharm editor Joseph Harvey was in attendance to gauge the reaction to the proposed new rules.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
Advertisement